What the numbers say
The most quoted figure comes from the Massachusetts Male Aging Study, a community-based survey of men aged 40 to 70 conducted near Boston in the late 1980s. It found a combined prevalence of minimal, moderate and complete difficulty of 52%, and that complete difficulty tripled from 5 to 15% between ages 40 and 70. Age was the variable most strongly associated with it.
A more recent US population study, published in Mayo Clinic Proceedings in 2009, gives cleaner numbers by decade:
| Age | Prevalence of ED |
|---|---|
| 40 to 49 | 2% |
| 50 to 59 | 6% |
| 60 to 69 | 17% |
| 70 and over | 39% |
The same study group also tracked how often it newly develops. Annual new cases rose from 12.4 per 1,000 men per year in the 40s, to 29.8 in the 50s, to 46.4 in the 60s. Roughly a fourfold increase across three decades.
The gap between the two studies is mostly a matter of how the question is asked. Broad definitions that include occasional difficulty produce much higher numbers than definitions requiring consistent difficulty. Both are true and they answer different questions.
The useful reading is not the headline percentage. It is that most men in every decade, including men past 70, do not have ED. It is common and it is not universal.
See if treatment is right for you
A short online visit lets a licensed provider review your history and recommend an approach.
Under 40
The decade tables start at 40, which leaves out a group that turns up in clinic more often than most men expect.
In a study of 439 consecutive men presenting with new erectile difficulty at an Italian andrology clinic, 114 of them, or 26%, were aged 40 or under. Severe ED was just as common in the younger group as the older one, at 48.8% against 40%.
That is a referral population rather than community prevalence, so it does not mean a quarter of young men have ED. It means ED under 40 is not the rarity it is assumed to be.
The causes skew differently. Psychological factors predominate, but at least 15 to 20% of young men with ED have an organic cause, so it is not safe to assume anxiety and move on. The pattern pointing psychological is sudden onset with reduced libido and good spontaneous erections.
ED under 40 carries more diagnostic weight, not less. Vascular disease is not expected at that age, so its presence is informative.
In your 40s
Prevalence is around 2% by the stricter definition, though occasional difficulty is far more common and generally not a sign of anything.
Psychological causes are proportionally more important here. Stress, work pressure, relationship strain, sleep deprivation and alcohol are frequent contributors. Men with predominantly psychological ED tend to be younger and free of cardiovascular disease.
In this decade, persistent ED in your 40s with no obvious explanation deserves proper investigation rather than just a prescription. This is the age at which it functions most clearly as an early warning, because vascular disease is not yet expected. Checking blood pressure, cholesterol, blood sugar and testosterone is a reasonable minimum.
In your 50s
Prevalence roughly triples to around 6%, and new cases more than double compared with the previous decade.
The mix of causes shifts. Vascular contributors become more prominent as blood pressure, cholesterol and blood sugar drift upward. Medication becomes a bigger factor, since this is the decade many men start treatment for blood pressure or cholesterol, and some of those drugs contribute.
This is also when the prostate enters the picture. Benign prostatic hyperplasia (BPH), a non-cancerous enlargement of the prostate, starts producing urinary symptoms in a meaningful minority of men in their 50s, and it travels with ED more often than chance would explain.
In this decade, if something changed, look at what else changed. A new prescription is the most commonly missed cause.
In your 60s
Prevalence reaches around 17%, and the annual rate of new cases is nearly four times what it was in the 40s.
Vascular causes now dominate. Diabetes, hypertension and atherosclerosis are the main drivers, and the same process affecting erections is affecting arteries elsewhere. Prostate treatment becomes a common contributor, both surgery and medications such as finasteride and dutasteride, which carry documented sexual side effects.
In this decade, mention urinary symptoms and erectile symptoms in the same appointment. The treatment chosen for one can worsen the other, and one medication treats both.
In your 70s and beyond
Prevalence reaches around 39%. Which still means the majority do not have it.
Causes here are usually multiple at once: vascular disease, several medications, reduced testosterone, other health conditions, and often a period without a partner. Treatment is still effective and still appropriate. Age alone is not a reason to withhold it, though it does raise the importance of checking drug interactions, particularly nitrates.
In this decade, cardiovascular fitness for sexual activity is the question worth asking, and it is usually answerable in a short conversation with your physician.
What actually drives the age curve
Age is a proxy rather than a cause. What accumulates with age is exposure to the things that damage blood vessels and nerves: years of high blood pressure, high cholesterol, elevated blood sugar, smoking, excess weight and inactivity.
Two men of the same age can therefore be in entirely different positions. Smoking cessation, aerobic exercise, weight reduction and control of blood pressure and blood sugar improve erectile function and cardiovascular risk through the same mechanism, because it is the same tissue doing the same job.
Age also brings a rising number of prescriptions, and medication is one of the more common and more reversible causes of ED at any age.
Where testosterone fits
Low testosterone gets blamed for ED more often than the evidence supports.
In a study of 1,022 men referred for ED, testosterone was low on initial testing in 107, but 40% of those were normal on repeat measurement. Repeatedly low testosterone was found in 4% of men under 50 and 9% of men 50 and over. Of those treated with androgen therapy, only 36% had a definite improvement, and 42% had a clear vascular contribution as well.
The distinction that matters is what testosterone actually drives. In the Testosterone Trials, involving 470 men, higher testosterone was associated with improvements in sexual activity and desire but not in erectile function. It is a libido hormone more than an erection hormone.
Replacement does help erections in the right men. A meta-analysis of 14 placebo-controlled trials covering 2,298 men found testosterone therapy improved erectile function against placebo, with the largest effect in men with the most severe deficiency. Its authors concluded testosterone alone is reasonable for hypogonadal men with milder ED, while more severe ED usually needs a PDE5 inhibitor as well.
Guidelines recommend measuring testosterone in men presenting with ED. Just do not expect it to be the answer on its own.
Takeaways
ED affects roughly 2% of men in their 40s, 6% in their 50s, 17% in their 60s and 39% past 70, with new cases rising about fourfold from the 40s to the 60s. It becomes more common with age without being inevitable, since the majority of men in every decade do not have it. The typical cause shifts from predominantly psychological in younger men toward predominantly vascular with age, with medication a common contributor throughout. Earlier onset carries more diagnostic weight, because in a younger man with no obvious explanation it is often the first sign of a cardiovascular problem worth catching.
Sources
- Inman BA, Sauver JL, Jacobson DJ, et al. A population-based, longitudinal study of erectile dysfunction and future coronary artery disease. Mayo Clinic Proceedings, 2009.
- Feldman HA, Goldstein I, Hatzichristou DG, et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. Journal of Urology, 1994.
- Johannes CB, Araujo AB, Feldman HA, et al. Incidence of ED in men 40 to 69 years old. Journal of Urology, 2000.
- Prostate Enlargement (Benign Prostatic Hyperplasia). National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health.



